News

Concord Biotech gains after successful EU-GMP inspection at Limbassi facility

Concord Biotech rose 3.30% to Rs 1,748.70 after the company announced successful completion of its first European Union Good Manufacturing Practice (EU-GMP) inspection at its active pharmaceutical ...
Capital Market on MSN45m

Concord Biotech's API unit in Limbassi concludes EU-GMP inspection

Concord Biotech announced that the European Union Good Manufacturing Practice (EU-GMP) authorities have conducted their first ...